Belgian biotech Galapagos is mixing things up again via a plan to split in two, separating its innovative medicines and cell therapy businesses, which will result in the loss of around 300 jobs or ...

Fresh from the $43 billion acquisition of antibody-drug conjugate (ADC) specialist Seagen, Pfizer has laid out plans for its dedicated oncology division in front of investors, aiming to add eight new ...

Visitors view the special exhibition on the making of the film Evil Unbound at the former site of the headquarters of the infamous Unit 731 of the Japanese army in Harbin, Heilongjiang province, on ...